One-way sensitivity analysis on the prevalence of diabetes, co-morbidity of diabetes and hypertension, and hypertension, resulting in different incremental cost-effectiveness ratios of ‘current PEN program’ and ‘universal screening’ compared with ‘no screening’. DM, diabetes; DMHT, diabetes with hypertension; HT, hypertension.